Table 5.
Factors associated with knowledge of the causative agent, route of malaria transmission, the use of paracetamol as antimalarial drug, and the number of preventive methods used.
| Factors | Causative agent of malaria | Routes of transmission | Use of paracetamol as antimalarial | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | n (%) | OR (95% CI) | P value | n (%) | OR (95% CI) | P value | n (%) | OR (95% CI) | P value | |
| Gender | ||||||||||
| Female | 458 | 58 (12.7%) | 1 | 430 (93.9) | 1 | 88 (19.2%) | 1 | |||
| Male | 2247 | 197 (8.8%) | 0.99 (0.70-1.39) | 0.938 | 2039 (90.7) | 0.88 (0.57-1.37) | 0.579 | 393 (17.5%) | 0.85 (0.64-1.12) | 0.245 |
| Age (years) | ||||||||||
| 19-36 | 1307 | 134 (10.3%) | 1 | 1195 (91.4) | 1 | 230 (17.6%) | 1 | |||
| 36-60 | 1351 | 119 (8.8%) | 0.98 (0.73-1.30) | 0.865 | 1236 (91.5) | 1.13 (0.85-1.51) | 0.394 | 240 (17.8%) | 1.08 (0.88-1.33) | 0.471 |
| ≥60 | 47 | 2 (4.3%) | 0.63 (0.14-2.76) | 0.537 | 38 (80.9) | 0.56 (0.24-1.30) | 0.180 | 11 (23.4%) | 1.54 (0.76-3.12) | 0.235 |
| Level of education | ||||||||||
| None/primary | 456 | 5 (1.1%) | 1 | 375 (82.2) | 1 | 91 (20.0%) | 1 | |||
| Lower secondary | 656 | 28 (4.3%) | 3.51 (1.34-9.23) | 0.0109∗ | 586 (89.3) | 1.74 (1.22-2.50) | 0.002∗ | 114 (17.4%) | 0.86 (0.63-1.18) | 0.361 |
| Upper secondary | 769 | 70 (9.1%) | 7.59 (3.00-19.19) | <0.0001∗ | 712 (92.6) | 2.29 (1.56-3.38) | <0.0001∗ | 127 (16.5%) | 0.86 (0.62-1.18) | 0.344 |
| Bachelor's degree | 505 | 94 (18.6%) | 14.30 (5.57-36.72) | <0.0001∗ | 484 (95.8) | 3.77 (2.13-6.70) | <0.0001∗ | 92 (18.2%) | 1.02 (0.71-1.49) | 0.897 |
| Master's degree and above | 319 | 58 (18.2%) | 12.81 (4.76-34.49) | <0.0001s | 312 (97.8) | 6.42 (2.60-15.90) | <0.0001∗ | 57 (17.9%) | 1.11 (0.70-1.76) | 0.447 |
| Professional category | ||||||||||
| Workers | 2176 | 158 (7.3%) | 1 | 1956 (89.9) | 1 | 394 (18.1%) | 1 | |||
| Managers | 529 | 97 (18.3%) | 1.46 (1.02-2.10) | 0.039∗ | 513 (97.0) | 1.54 (0.83-2.86) | 0.173 | 87 (16.4%) | 0.88 (0.63-1.23) | 0.667 |
| Residence | ||||||||||
| Douala 1 | 325 | 24 (7.4%) | 1 | 285 (87.7) | 1 | 61 (18.8%) | 1 | |||
| Douala 2 | 221 | 18 (8.1%) | 1.64 (0.83-3.26) | 0.154 | 189 (85.5) | 1.11 (0.65-1.89) | 0.704 | 38 (17.2%) | 0.79 (0.50-1.23) | 0.447 |
| Douala 3 | 1345 | 124 (9.2%) | 1.51 (0.92-2.49) | 0.102 | 1237 (92.0) | 1.63 (1.06-2.50) | 0.026∗ | 252 (18.7%) | 0.96 (0.69-1.34) | 0.811 |
| Douala 4 | 174 | 20 (11.5%) | 1.76 (0.91-3.40) | 0.093 | 160 (92.0) | 1.63 (0.84-3.16) | 0.148 | 18 (10.3%) | 0.50 (0.28-0.88) | 0.016∗ |
| Douala 5 | 568 | 64 (11.3%) | 1.31 (0.78-2.20) | 0.309 | 532 (93.7) | 1.51 (0.91-2.49) | 0.110 | 99 (17.4%) | 0.91 (0.63-1.31) | 0.597 |
| Out of Douala | 27 | 1 (3.7%) | 0.50 (0.06-4.07) | 0.521 | 25 (92.6) | 1.49 (0.33-6.75) | 0.606 | 7 (25.9%) | 1.48 (0.59-3.72) | 0.404 |
| Enterprises | ||||||||||
| ENT 1 | 104 | 5 (4.8%) | 1 | 89 (85.6) | 1 | 13 (12.5%) | 1 | |||
| ENT 2 | 78 | 4 (5.1%) | 1.77 (0.44-7.05) | 0.421 | 64 (82.1) | 1.05 (0.46-2.39) | 0.916 | 12 (15.4%) | 1.20 (0.51-2.83) | 0.675 |
| ENT 3 | 44 | 5 (11.4%) | 1.92 (0.51-7.19) | 0.334 | 43 (97.7) | 5.17 (0.65-41.21) | 0.121 | 9 (20.5%) | 1.76 (0.68-4.54) | 0.243 |
| ENT 4 | 276 | 56 (20.3%) | 4.06 (1.54-10.70) | 0.004∗ | 255 (92.4) | 1.59 (0.76-3.33) | 0.221 | 56 (20.3%) | 1.63 (0.84-3.17) | 0.148 |
| ENT 5 | 275 | 10 (3.6%) | 1.20 (0.39-3.70) | 0.748 | 228 (82.9) | 1.20 (0.62-2.35) | 0.587 | 57 (20.7%) | 1.84 (0.95-3.57) | 0.071 |
| ENT 6 | 113 | 24 (21.2%) | 3.49 (1.25-9.81) | 0.017∗ | 108 (95.6) | 2.51 (0.85-7.46) | 0.097 | 21 (18.6%) | 1.50 (0.70-3.22) | 0.299 |
| ENT 7 | 178 | 16 (9.0%) | 2.33 (0.81-6.71) | 0.117 | 166 (93.3) | 2.60 (1.14-5.92) | 0.023∗ | 31 (17.4%) | 1.53 (0.76-3.11) | 0.235 |
| ENT 8 | 132 | 8 (6.1%) | 1.18 (0.37-3.80) | 0.785 | 116 (87.9) | 1.22 (055-2.72) | 0.627 | 17 (12.9%) | 0.99 (0.46-2.17) | 0.989 |
| ENT 9 | 408 | 21 (5.1%) | 1.66 (0.59-4.65) | 0.338 | 363 (89.0) | 1.69 (0.86-3.31) | 0.125 | 90 (22.1%) | 188 (0.99-3.58) | 0.054 |
| ENT 10 | 147 | 9 (6.1%) | 1.00 (0.31-3.20) | 0.997 | 141 (95.9) | 3.55 (1.30-9.69) | 0.013∗ | 28 (19.0%) | 1.54 (0.75-3.17) | 0.236 |
| ENT 11 | 104 | 13 (12.5%) | 2.57 (0.86-7.70) | 0.092 | 100 (96.2) | 3.89 (1.21-12.53) | 0.022∗ | 13 (12.5%) | 0.95 (0.41-2.18) | 0.900 |
| ENT 12 | 65 | 2 (3.1%) | 0.69 (0.13-3.72) | 0.661 | 61 (93.8) | 2.80 (0.87-9.07) | 0.085 | 10 (15.4%) | 1.16 (0.47-2.83) | 0.749 |
| ENT 13 | 143 | 18 (12.6%) | 1.77 (0.44-7.05) | 0.421 | 135 (94.4) | 1.46 (0.57-3.74) | 0.431 | 15 (10.5%) | 0.77 (0.34-1.71) | 0.514 |
| ENT 14 | 638 | 64 (10.0%) | 1.86 (0.72-4.85) | 0.201 | 600 (94.0) | 2.26 (1.15-4.45) | 0.017∗ | 109 (17.1%) | 1.29 (0.69-2.42) | 0.427 |
OR : odds ratio; 95% CI: confidence interval at 95%. Multivariate logistic regression model was used to compute OR. ∗Statistically significant at P < 0.05.